Merck & Company, Inc. vs Thermo Fisher Scientific Inc — Stock Comparison
Merck & Company, Inc. (MRK) and Thermo Fisher Scientific Inc (TMO) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Thermo Fisher Scientific Inc narrowly edges Merck & Company, Inc. on Q·Score (7.5 vs 7 out of 10), led by Valuation (8.2 vs 6.7) and Sentiment (8.1 vs 7.1). Merck & Company, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for TMO (+29.0%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 19% return on equity and 14% profit margins.
Consensus analyst target of $599.19 is 29% above current price.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs TMO: which stock scores better overall?
Based on Q·Score, Thermo Fisher Scientific Inc (TMO) scores 7.5/10 versus Merck & Company, Inc. (MRK) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or TMO?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 6.1/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Thermo Fisher Scientific Inc reports (6.2% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or TMO more attractively valued?
Thermo Fisher Scientific Inc (TMO) scores higher on Valuation (8.2/10 vs 6.7/10). MRK trades at 11.9× P/E versus TMO at 17.1×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs TMO?
There are 27 analysts covering MRK with a consensus price target of $129.74, and 26 analysts covering TMO with a consensus target of $599.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or TMO?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 7.7/10). Net profit margin: MRK at 13.6%, TMO at 15.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Financial Health (7.6/10 vs 7/10). Market beta: MRK at 0.22, TMO at 0.87. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and TMO?
Merck & Company, Inc. (MRK) has a market capitalisation of $281.2B, while Thermo Fisher Scientific Inc (TMO) has a market cap of $172.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or TMO pay dividends?
MRK pays a dividend yield of 2.95%, while TMO pays a dividend yield of 0.40%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →